arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Bio Green Med Solution, Inc.

BGMS
$0.89 ▲ +0.03 (+2.92%) at close
Industrials ·Wholesale-Durable Goods, NEC ·USWholesale-Durable Goods, NEC
80 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

Bio Green Med Solution, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.0M
Dividend Yield —
Revenue Growth None
Op. Margin -117.1% ↘
ROIC -6.0% ↘
FCF / Share $-0.06 ↘
Trailing P/E —
Price / Book 0.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

80-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$357.00K
↓ -52.0% —
Net Income Profit after all expenses
$-197.00K
↓ -143.2% —
Operating Margin Operating profit as % of sales
-117.1%
↓ -253.6% —
FCF / Share Free cash flow per share
$-0.06
↓ -23.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑
18
Financial Health ↓
4
Cash Quality ↑
81

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 30 years · 80 quarters